Expanding the therapeutic use of androgens via selective androgen receptor modulators (SARMs)WENQING GAO; DALTON, James T.Drug discovery today. 2007, Vol 12, Num 5-6, pp 241-248, issn 1359-6446, 8 p.Article

Pharmacokinetics and pharmacodynamics of nonsteroidal androgen receptor ligandsWENQING GAO; KIM, Juhyun; DALTON, James T et al.Pharmaceutical research. 2006, Vol 23, Num 8, pp 1641-1658, issn 0724-8741, 18 p.Article

Discovery of 2-arylthiazolidine-4-carboxylic acid amides as a new class of cytotoxic agents for prostate cancerGUDUDURU, Veeresa; HURH, Eunju; DALTON, James T et al.Journal of medicinal chemistry (Print). 2005, Vol 48, Num 7, pp 2584-2588, issn 0022-2623, 5 p.Article

Synthesis and antiproliferative activity of 2-aryl-4-oxo-thiazolidin-3-yl-amides for prostate cancerGUDUDURU, Veeresa; HURH, Eunju; DALTON, James T et al.Bioorganic & medicinal chemistry letters (Print). 2004, Vol 14, Num 21, pp 5289-5293, issn 0960-894X, 5 p.Article

Cytochrome P-450 2C9 sensitizes human prostate tumor cells to cyclophosphamide via a bystander effectDIANSONG ZHOU; YI LU; STEINER, Mitchell S et al.Antimicrobial agents and chemotherapy. 2000, Vol 44, Num 10, pp 2659-2663, issn 0066-4804Article

ERβ Selective Agonist Inhibits Angiotensin-Induced Cardiovascular Pathology in Female MicePEDRAM, Ali; RAZANDI, Mahnaz; KORACH, Kenneth S et al.Endocrinology (Philadelphia). 2013, Vol 154, Num 11, pp 4352-4364, issn 0013-7227, 13 p.Article

Role and pharmacologic significance of cytochrome P-450 2D6 in oxidative metabolism of toremifene and tamoxifenKIM, Juhyun; COSS, Christopher C; BARRETT, Christina M et al.International journal of cancer (Print). 2013, Vol 132, Num 6, pp 1475-1485, issn 0020-7136, 11 p.Article

Biotransformation of a Novel Antimitotic Agent, I-387, by Mouse, Rat, Dog, Monkey, and Human Liver Microsomes and In Vivo Pharmacokinetics in MiceAHN, Sunjoo; KEARBEY, Jeffrey D; LI, Chien-Ming et al.Drug metabolism and disposition. 2011, Vol 39, Num 4, pp 636-643, issn 0090-9556, 8 p.Article

Discovery and Mechanistic Characterization of a Novel Selective Nuclear Androgen Receptor Exporter for the Treatment of Prostate CancerNARAYANAN, Ramesh; YEPURU, Muralimohan; SZAFRAN, Adam T et al.Cancer research (Chicago, Ill.). 2010, Vol 70, Num 2, pp 842-851, issn 0008-5472, 10 p.Article

Development and Validation of a Highly Sensitive Liquid Chromatography/Mass Spectrometry Method for Simultaneous Quantification of Lenalidomide and Flavopiridol in Human PlasmaQING LIU; FARLEY, Katherine L; PHELPS, Mitch A et al.Therapeutic drug monitoring. 2008, Vol 30, Num 5, pp 620-627, issn 0163-4356, 8 p.Article

SAR studies of 2-arylthiazolidine-4-carboxylic acid amides : A novel class of cytotoxic agents for prostate cancerGUDUDURU, Veeresa; HURH, Eunju; SULLIVAN, Joshua et al.Bioorganic & medicinal chemistry letters (Print). 2005, Vol 15, Num 18, pp 4010-4013, issn 0960-894X, 4 p.Article

A ligand-based approach to identify quantitative structure-activity relationships for the androgen receptorBOHL, Casey E; CHENG CHANG; MOHLER, Michael L et al.Journal of medicinal chemistry (Print). 2004, Vol 47, Num 15, pp 3765-3776, issn 0022-2623, 12 p.Article

Comparison of the pharmacological effects of a novel selective androgen receptor modulator, the 5α-reductase inhibitor finasteride, and the antiandrogen hydroxyflutamide in intact rats: New approach for benign prostate hyperplasiaWENQING GAO; KEARBEY, Jeffrey D; NAIR, Vipin A et al.Endocrinology (Philadelphia). 2004, Vol 145, Num 12, pp 5420-5428, issn 0013-7227, 9 p.Article

Synthesis, in vitro structure-activity relationship, and in vivo studies of 2-arylthiazolidine-4-carboxylic acid amides as anticancer agentsYAN LU; ZHAO WANG; LI, Chien-Ming et al.Bioorganic & medicinal chemistry. 2010, Vol 18, Num 2, pp 477-495, issn 0968-0896, 19 p.Article

Competitive mass spectrometry binding assay for characterization of three binding sites of tubulinLI, Chien-Ming; YAN LU; AHN, Sunjoo et al.Journal of mass spectrometry. 2010, Vol 45, Num 10, pp 1160-1166, issn 1076-5174, 7 p.Article

A novel liposomal formulation of flavopiridolXIAOJUAN YANG; XIAOBIN ZHAO; DALTON, James T et al.International journal of pharmaceutics (Print). 2009, Vol 365, Num 1-2, pp 170-174, issn 0378-5173, 5 p.Article

Nonsteroidal Selective Androgen Receptor Modulators (SARMs): Dissociating the Anabolic and Androgenic Activities of the Androgen Receptor for Therapeutic BenefitMOHLER, Michael L; BOHL, Casey E; JONES, Amanda et al.Journal of medicinal chemistry (Print). 2009, Vol 52, Num 12, pp 3597-3617, issn 0022-2623, 21 p.Article

Effects of Selective Androgen Receptor Modulator (SARM) Treatment in Osteopenic Female RatsKEARBEY, Jeffrey D; WENQING GAO; FISHERY, Scott J et al.Pharmaceutical research. 2009, Vol 26, Num 11, pp 2471-2477, issn 0724-8741, 7 p.Article

Development and validation of a sensitive liquid chromatography/mass spectrometry method for quantitation of flavopiridol in plasma enables accurate estimation of pharmacokinetic parameters with a clinically active dosing schedulePHELPS, Mitch A; ROZEWSKI, Darlene M; JOHNSTON, Jeffrey S et al.Journal of chromatography. B. 2008, Vol 868, Num 1-2, pp 110-115, issn 1570-0232, 6 p.Article

Apoptosis induced by novel aldehyde calpain inhibitors in human tumor cell linesNA GUAN; KORUKONDA, Rajani; HURH, Eunju et al.International journal of oncology. 2006, Vol 29, Num 3, pp 655-663, issn 1019-6439, 9 p.Article

Design, synthesis, and biological characterization of metabolically stable selective androgen receptor modulatorsMARHEFKA, Craig A; WENQING GAO; KIWON CHUNG et al.Journal of medicinal chemistry (Print). 2004, Vol 47, Num 4, pp 993-998, issn 0022-2623, 6 p.Article

Structural determinants of P-glycoprotein-mediated transport of glucocorticoidsYATES, Charles R; CHENG CHANG; KEARBEY, Jeffrey D et al.Pharmaceutical research. 2003, Vol 20, Num 11, pp 1794-1803, issn 0724-8741, 10 p.Article

Pharmacokinetics, pharmacodynamics and metabolism of a novel anticancer agent for prostate cancerJUN YANG; AHN, Sunjoo; WU, Zengru et al.International journal of oncology. 2012, Vol 41, Num 1, pp 337-344, issn 1019-6439, 8 p.Article

Orally Bioavailable Tubulin Antagonists for PaclitaxelRefractory Cancer : Drugs Targeting Tubulin PolymerizationLI, Chien-Ming; YAN LU; DALTON, James T et al.Pharmaceutical research. 2012, Vol 29, Num 11, pp 3053-3063, issn 0724-8741, 11 p.Article

Pharmacokinetic Optimization of 4-Substituted Methoxybenzoyl-aryl-thiazole and 2-Aryl-4-benzoyl-imidazole for Improving Oral BioavailabilityLI, Chien-Ming; JIANJUN CHEN; YAN LU et al.Drug metabolism and disposition. 2011, Vol 39, Num 10, pp 1833-1839, issn 0090-9556, 7 p.Article